Login to Your Account

Buy low, sell high? Biotech blow-ups can reap long-term upside

By Marie Powers
Staff Writer

Monday, March 17, 2014

Should investors run from a biotech stock that blows up, taking a one-day dive of 25 percent or more? Or should they add more shares? What about jumping aboard the biotech pop-ups – the companies that see a gain of 25 percent or more in a single day?

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription